WS #13276
AstraZeneca and Bristol Myers Squibb reportedly in talks for a $400B merger, a major healthcare M&A event.
AstraZeneca-Bristol Myers merger talks
AstraZeneca and Bristol Myers Squibb reportedly in talks for a $400B merger, a major healthcare M&A event.